December 15, 2022
JEMA Chairman Hiroshi Matsumori (center) and Satoshi Shiratori, President of Shiratori Pharmaceutical (left) The Japan Established Medicine Association (JEMA) issued a proposal on December 13 urging the health ministry to adopt more relaxed regulations on API specifications on par with...read more